Imported infection counts are not a destination risk ranking

A table of infections reported after overseas travel can look like a league table of dangerous destinations. It is not. The figures describe people who travelled, became infected and were reported through particular surveillance systems. They do not show how many people made the same trip without becoming ill, or turn one country into a simple red or green label.

That distinction matters in the provisional travel-associated infection data published by the UK Health Security Agency on 14 July. The update covers dengue, Zika virus disease, chikungunya, malaria and enteric fever, which means it also covers different routes of exposure. Some are spread by mosquitoes. Typhoid and paratyphoid are usually linked to contaminated food or water. A single generic holiday-health checklist cannot express all of that.

UKHSA reported 137 dengue cases in England from January to June 2026. South-East Asia and South Asia were the most common broad exposure regions, with 27 cases linked to travel to Thailand and 19 to the Maldives. There were also eight reported Zika cases during the same six months across England, Wales and Northern Ireland, already one more than the seven recorded in all of 2025. Four of the eight were linked to Indonesia.

Those small Zika numbers need particularly careful reading. The change from seven cases in one full year to eight in half a year is a surveillance signal, not a population risk rate. The data does not include a denominator for trips, testing or exposure. UKHSA highlights Zika because infection during pregnancy can pose a serious risk to an unborn baby, while many infected people have no symptoms or only mild illness. That combination makes current, destination-specific professional guidance more useful than a dramatic headline built from a single-digit count.

Chikungunya adds another pattern. UKHSA recorded 59 cases from January to June, with Sri Lanka the most commonly reported country of travel at 18 cases. Dengue, Zika and chikungunya can share mosquito vectors and can produce overlapping symptoms, but their surveillance totals are not interchangeable. A country appearing in one column does not prove it is absent from another risk map, and a reported case count is not a forecast for an individual trip.

The time windows are not identical either. UKHSA reported 557 imported malaria cases in England, Wales and Northern Ireland from January to May, one month less than the period used for the other new half-year figures. It also recorded 287 travel-associated cases of enteric fever, meaning typhoid and paratyphoid, from January to June. Putting every number on one chart without those labels would create a cleaner graphic and a worse explanation.

What the figures can do is reveal why travel-health preparation begins with a destination, an itinerary and a date rather than a universal packing list. The NHS says the vaccinations relevant to a trip depend on both the country and the part of the country being visited. It points travellers to TravelHealthPro, the UK travel-health service supported by UKHSA, which maintains destination pages and current outbreak information. NHS guidance also notes that some vaccine courses take time, so professional advice is generally considered four to six weeks before travel where possible.

UKHSA’s current public message similarly separates the practical routes. It advises mosquito-bite precautions such as repellent, covered skin and treated bed nets where needed. It also points to food and water hygiene, routine vaccination status, destination-specific travel vaccines and malaria prevention medicines where appropriate. Pregnancy, plans to conceive, existing health conditions and the details of an itinerary can change the relevant advice, which is why a surveillance table cannot safely make the decision on its own.

There is a second common misreading to avoid. These are imported or travel-associated reports. They are not evidence that dengue, Zika, chikungunya, malaria, typhoid and paratyphoid are all spreading locally in Britain. The statistics are valuable partly because laboratories and public-health teams can connect an infection diagnosed after return with likely travel exposure. That helps officials detect patterns and update advice, even when the risk remains overseas.

Nor do the figures support blaming travellers or destinations. Counts are shaped by where people travel, how long they stay, what they do, whether they seek care, whether clinicians test, and how reports reach the surveillance system. UKHSA has called the current data provisional. Later reports may revise or add detail.

The honest reader takeaway is therefore modest. Today’s figures are a prompt to open the destination page before closing the suitcase. They show that imported infections still arrive through several routes during the summer travel season. They do not provide a universal danger ranking, a diagnosis or a personal prevention plan. The map has to come before the number.